Related Experiment Videos
Use and interpretation of rheumatologic tests: a guide for clinicians
1Division of Rheumatology, Mayo Clinic Rochester, MN 55905 USA.
Mayo Clinic Proceedings
|April 1, 1996
Summary
New autoantibody tests, including antineutrophil cytoplasmic antibody (ANCA) and myositis-specific antibodies, aid rheumatology diagnoses. Interpreting these and established tests requires considering clinical context and test performance values.
Area of Science:
- Rheumatology
- Immunology
- Clinical Diagnostics
Background:
- Emerging autoantibody tests are increasingly utilized in rheumatology.
- Established tests like antinuclear antibodies (ANA) and extractable nuclear antibodies (ENA) are crucial for diagnosing connective tissue diseases.
- Antineutrophil cytoplasmic antibody (ANCA) tests show cytoplasmic (c-ANCA) or perinuclear (p-ANCA) patterns.
Purpose of the Study:
- To review the clinical utility of new autoantibody tests.
- To discuss the integration of new tests with established autoantibody testing.
- To highlight the importance of test performance metrics in interpretation.
Main Methods:
- Literature review of new and established autoantibody tests.
- Discussion of diagnostic applications in rheumatology.
- Emphasis on interpreting autoantibody results within clinical context.
Main Results:
- New tests like ANCA and myositis-specific antibodies (e.g., anti-Jo1) offer valuable diagnostic information.
- ANA and ENA remain essential for diagnosing connective tissue diseases.
- The anti-Jo1 antibody test is particularly useful for diagnosing idiopathic inflammatory myopathy.
Conclusions:
- Accurate interpretation of autoantibody tests necessitates understanding their sensitivity, specificity, and predictive values.
- Clinical correlation and analysis of multiple autoantibody results are vital for accurate diagnosis.
- New autoantibody tests enhance diagnostic capabilities in rheumatology when used judiciously.